Illinois News Joint

FEBRUARY 8, 2023

With a philosophy rooted in trauma-informed care, they believe in client-led healing and strive to truly listen and collaborate with patients to create individualized treatment plans that meet unique needs and lifestyles. One of our main goals is to increase the accessibility and affordability of medical cannabis as a treatment.”

Patients 98

Patients Treatment Environment Conditions 98

Cannabis Law Report

FEBRUARY 27, 2020

The EAMC hosted an event at the recent Cannabis Europa conference in Madrid to mark its entry to the market. The European Alliance for Medicinal Cannabis (EAMC) is a Brussels-based, industry-led organisation representing medical cannabis licensed producers across the European Union.

Law 102

Law Medicine Compliance Compliance 102

Veriheal

JUNE 29, 2022

Consequently, psychedelics have received a significant amount of attention for ailments that are in need of more effective solutions, such as treatment-resistant depression (TRD). Exploring Psilocybin and Treatment-Resistant Depression. Earlier this year, psilocybin was investigated as a means of assisting with TRD.

Clinical Trials 105

Clinical Trials Blood Pressure Treatment Therapy 105

Cannabis Law Report

NOVEMBER 17, 2021

There is one problem, Malaysia currently has no registered cannabis-based treatment. In a press event, public health minister, Anutin Charnvirakul said that the ministry would promote medical cannabis to help people access treatment safely and within the law. Importers would be required to hold permits and licenses.

Research and Development 111

Research and Development Treatment Patients Pharmaceutical 111

Cannabis Law Report

JULY 24, 2021

This expansive patent would allow Mydecine to scale its coverage in drug development research in lieu of promising discoveries and FDA-approval progress for novel therapeutics, including granting Breakthrough Therapy Designation to MDMA for the treatment of PTSD in recent years. About Mydecine Innovations Group.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? At this time, there is little in the way for combat-related PTSD treatment specifically. Let’s find out. .

Treatment 105

Treatment Sleep Clinical Trials Data 105

Cannabis Law Report

JULY 22, 2021

A master distribution agreement has been signed with My Green Planet, a leading global agricultural supply group, giving Sporeo access to approximately 7,000 retailers across North America, Australia, and Europe. Levitee Labs aims to catalyze access to compounds and alternative medicines that enhances the wellbeing of society.

eCommerce 105

eCommerce Therapy Media Access 105

NORML

OCTOBER 30, 2019

To honor both those who have bravely served and those who still suffer due to federal cannabis laws, Nevada NORML will be hosting a unique event on Veteran’s Day.

Media 104

Media Legislation Events Banking 104

Veriheal

AUGUST 21, 2023

Implications of Cohen’s Donation on Psychedelic Studies MAPS intends to submit an MDMA drug application to FDA this year to be approved for mental health treatment. If the FDA approves the application, it will pave the way for integrating psychedelic treatment into mainstream medical health care.

Therapy 95

Therapy Research and Development Treatment Environment 95

NORML

NOVEMBER 5, 2019

To honor both those who have bravely served and those who still suffer due to federal cannabis laws, Nevada NORML will be hosting a unique event on Veteran’s Day.

Media 100

Media Legislation Events Banking 100

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives. .

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JUNE 14, 2022

Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD. However, there is a growing realization that European health systems may not be prepared for these treatments. Psychedelic compounds – such as psilocybin and MDMA – are one such extremely promising area.

Access 52

Access Therapy Clinical Trials Treatment 52

Project CBD

DECEMBER 31, 2022

In recent years, psilocybin and MDMA have been explored as potential treatments for post-traumatic stress disorder, but somewhat more quietly so has cannabis. Adverse events related to cannabis use were predominately mild or moderate, with insomnia and fatigue being most common at 20 incidents each.

Sleep 130

Sleep Patients Treatment Cannabis 130

Veriheal

MAY 30, 2023

But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? of patients experience pain after curative treatment, while 66.4% in cancer patients undergoing anticancer treatment, 50.7% in those who had completed treatment, and as high as 66.7%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

FEBRUARY 14, 2022

Our families and communities are suffering, and we urgently need access to preventative and curative medicines and medical care that is safe and effective. These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine.

Medicine 52

Medicine Access Therapy Treatment 52

MMJ Recs

JULY 11, 2024

Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. It is often caused by life events such as stress, anxiety, or a significant change in routine. Chronic insomnia often requires a more comprehensive treatment approach.

Sleep 111

Sleep Treatment Research and Development Therapy 111

CannaTech

JUNE 30, 2019

These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. The Israeli Ministry of Health is being scrutinized and criticized for failing to adequately provide access to medical cannabis where justifiably prescribed.

Patients 90

Patients Oil Epilepsy Strains 90

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

JUNE 7, 2021

Note: Veriheal does not support illegally consuming therapeutic substances like MDMA but acknowledges that it transpires because of the current illicit status of both, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Therapy 92

Therapy Treatment Conditions Clinical Trials 92

Cannabis Law Report

JULY 28, 2021

This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies. “KGK The recent addition of KGK Science Inc. On behalf of: KETAMINE ONE.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Veriheal

JUNE 30, 2023

To start, participants reported that psilocybin had helped them process emotions tied to painful events in their past. Additionally, participants also reported feeling increased self-awareness and general improvement in relationships following their treatment. The Summit found that cannabis does not enhance athletic performance.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JUNE 8, 2021

Psilocybin and related compounds have shown strong anti-inflammatory effects in non-human animals, raising the possibility that reducing inflammation is a possible mechanism underlying psilocybin’s positive treatment effects in multiple disorders. The study will take place at The Translational Psychedelic Research (TrPR) Program at UCSF.

Patients 70

Patients Research and Development Clinical Trials Chronic Pain 70

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Cannabis Law Report

FEBRUARY 12, 2023

Event description Don’t miss out – Get your tickets early! Join this FREE, 75-minute online webinar to gain access to insights and learn about ground-breaking treatments to chronic mental health conditions.

Policy 52

Policy Medicine Events Treatment 52

Cannabis Law Report

JULY 7, 2021

is a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments. It is working to provide the critical infrastructure needed to develop and deliver breakthrough mental health treatments. KetamineOne Capital Limited (formerly Myconic Capital Corp.) On behalf of: KETAMINE ONE.

Research and Development 98

Research and Development Treatment Therapy Banking 98

Cannabis Law Report

JULY 14, 2021

The exploratory trial was the latest of several small trials where ImmunoFlex has focused on analysing immune system modulation at a genomic level resulting from treatment with compounds including CBD, THC, NAC and several other widely available compounds. Forward-looking statements are statements that relate to future, not past, events.

Research and Development 81

Research and Development Clinical Trials Events Treatment 81

MMJ Recs

MARCH 30, 2022

Recently, patient drives in Pennsylvania have made MMJ cards accessible to a lot of PA residents. Pennsylvania patient drives have helped thousands of people to avail of MMJ treatment in PA. Why are Pennsylvania patient drive events great for patients and dispensaries? Patient Drives In Pennsylvania.

Patients 52

Patients Dispensary Events Treatment 52

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. The call can be accessed by dialing (833) 665-0659 from the United States, +1 (914) 987-7313 internationally, and 0800 028 8438 from the UK, followed by the conference ID: 3495828.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

JULY 12, 2021

Late last week we published an article attributing comments about not legalizing psychedelic compounds to Rick Doblin at a event held by Prohibition Partners. It is the closest of any organization to getting a psychedelic substance approved as a medical treatment by the US Food and Drug Administration. The company has a $2.7

Research and Development 75

Research and Development Decriminalization Treatment Access 75

CannaMD

APRIL 19, 2020

As the coronavirus crisis continues, CannaMD remains committed to helping patients access treatment as safely as possible. Rise is celebrating with a special virtual event: Let’s celebrate the moments that remind us why we believe in the power of this plant and our right to choose it! Some restrictions may apply. Get Started.

Seed-To-Sale 94

Seed-To-Sale Marijuana Wellness and Beauty Patients 94

Cannabis Law Report

JUNE 29, 2022

The worlds of cannabis and psychedelics are coming together in a single event to dispel stigmas, promote science, and battle the mental health crisis. The event is the most accessible of its kind offering free admission for all to its expo and networking floor. Event details are as follows. Registration – [link].

Events 52

Events Education Therapy Access 52

MMJ Recs

APRIL 10, 2022

OK patient drives have improved medical marijuana accessibility for people living in and visiting the Sooner State. Why are OK patient drive events great for patients and dispensaries? Why Are OK Patient Drive Events Great For Patients And Dispensaries? MMJ is proven to have huge pain-relieving and life-enhancing benefits.

Patients 52

Patients Dispensary Events Conditions 52

Veriheal

FEBRUARY 28, 2021

It helps to showcase the 103 countries holding events on this day as well as the thousands of events hosted online worldwide. This year, COVID-19 has dramatically impacted the way events are hosted. Instead of having physical locations, many events have opted to go digital being held online.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

Cannabis Law Report

JUNE 19, 2022

A new alliance aiming to help hone the therapeutic potential of psychedelics is set to emerge from Europe, making its debut via a virtual event later this month. We are equally excited about the inaugural launch of the Psychedelic Access and Research European Alliance! See the event schedule below: PAREA Launch Agenda.

Therapy 52

Therapy Advocacy Events Treatment 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). Le-Short C.,

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JUNE 29, 2021

(“Ava Pathways”), remains focused on neuroplasticity and alternative ways to treat common and debilitating medical conditions such as depression, anxiety, PTSD, and substance use disorder, through the use of psychedelic-based treatments. The Company offers a reimagined vision for craft markets through collaboration, expertise, and adaptation.

CBD 95

CBD Events Recreational Cannabinoids 95